Five-year DFS rates were 44.4%, 66.1%, and 73.1% in Groups 1, 2, and 3, respectively; although DFS numerically improved across the groups, this difference did not reach statistical significance (p = 0.186).
← all excerpts
Prognostic significance of integrating pretreatment biopsy-derived Immunoscore and Pan-Immune-Inflammation value in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
1
0.1860
0.1860